Autres langues Iris Acquisition Corp

Actions

IRAA

US89601Y1010

Temps réel estimé Cboe BZX Autres places de cotation 15:35:08 06/05/2024			Varia. 5j.	Varia. 1 janv.
10,64 ^USD	+2,55%		0,00%	+0,48%

17/04	Iris Acquisition Corp présente ses résultats pour l'exercice clos le 31 décembre 2023	CI
12/01	Iris Acquisition Corp présente ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023	17/04
Iris Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	12/01
Iris Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K	02/01
Iris Acquisition Corp announced that it has received $1.5 million in funding	04/10/23
Iris Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23
Iris Acquisition Corp Appoints Nicholas Fernandez as Director	02/06/23
Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	02/05/23
Iris Acquisition Corp Announces Resignation of Borade as A Member of the Board	02/05/23
IRIS ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	18/04/23
Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022	18/04/23
FTX revival effort draws possible bid from VC firm Tribe Capital - Bloomberg News	18/04/23
Iris Acquisition Corp Auditor Raises 'Going Concern' Doubt	18/04/23
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	31/03/23
IRIS ACQUISITION CORP : Change in Directors or Principal Officers (form 8-K)	19/01/23
Iris Acquisition Corp Appoints Borade Shashibhushan to Serve as A Director	19/01/23
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	28/12/22
IRIS ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23/12/22
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	20/12/22
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp	06/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Iris Acquisition Corp

Actions

IRAA

US89601Y1010

Autres langues

Filtres